Evidence map›Paper›PMID 32264928›Full record

ReviewJournal of neuroinflammation2020

The role of Toll-like receptor signaling pathways in cerebrovascular disorders: the impact of spreading depolarization.

Rezan Ashayeri Ahmadabad, Maryam Khaleghi Ghadiri, Ali Gorji

Open access · goldAbstract readReview
In one paragraph

Review in Journal of neuroinflammation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Neuroinflammation: The Pathogenic Mechanism of Neurological Disorders.International journal of molecular sciences · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Rezan Ashayeri AhmadabadShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
Maryam Khaleghi GhadiriDepartment of Neurosurgery, Westfälische Wilhelms-Universität Münster, Münster, Germany.
Ali GorjiShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran. gorjial@uni-muenster.de.
Khatam University · IRUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral vascular diseases (CVDs) are a group of disorders that affect the blood supply to the brain and lead to the reduction of oxygen and glucose supply to the neurons and the supporting cells. Spreading depolarization (SD), a propagating wave of neuroglial depolarization, occurs in different CVDs. A growing amount of evidence suggests that the inflammatory responses following hypoxic-ischemic insults and after SD plays a double-edged role in brain tissue injury and clinical outcome; a beneficial effect in the acute phase and a destructive role in the late phase. Toll-like receptors (TLRs) play a crucial role in the activation of inflammatory cascades and subsequent neuroprotective or harmful effects after CVDs and SD. Here, we review current data regarding the pathophysiological role of TLR signaling pathways in different CVDs and discuss the role of SD in the potentiation of the inflammatory cascade in CVDs through the modulation of TLRs.

Indexed as

AnimalsCerebrovascular DisordersCortical Spreading DepressionHumansSignal TransductionToll-Like ReceptorsToll-Like ReceptorsBrainChemokinesInflammatory mediatorsSpreading depolarizationStrokeSubarachnoid hemorrhageToll-like receptors

Identifiers

PMID32264928
PMCPMC7140571
OpenAlexW3014518155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.